# FDA Inspection 1106255 - LGGS Florida, Inc - September 17, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/lggs-florida-inc/fc98e557-a1bb-4daf-8b5f-9d28c0c422ce/
Source feed: FDA_Inspections

> FDA Inspection 1106255 for LGGS Florida, Inc on September 17, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106255
- Company Name: LGGS Florida, Inc
- Inspection Date: 2019-09-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 797348 - 2012-09-05](https://www.globalkeysolutions.net/api/records/fda_inspections/lggs-florida-inc/bbffef11-56bd-4846-86af-07597912960b/)
- [FDA Inspection 713888 - 2011-03-09](https://www.globalkeysolutions.net/api/records/fda_inspections/lggs-florida-inc/2808d6ee-1192-4acd-8e73-7bd64d31c5dc/)

Company: https://www.globalkeysolutions.net/companies/lggs-florida-inc/8e4e7324-8e38-4395-b137-4fc4842e69ea

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d